BioTime Announces Passing of Director Abraham E. Cohen ALAMEDA, Calif.--(BUSINESS WIRE)

Announces Passing of Director Abraham E. Cohen

ALAMEDA, Calif.--(BUSINESS WIRE)--November 26, 2012--BioTime, Inc. (NYSE

MKT: BTX) announced with sadness that Abraham (Barry) E. Cohen, a member

of its Board of Directors, passed away on Thursday, November 22, 2012 at

Mr. Cohen has been a valued member of the Board of Directors and was a

member of several committees, including the Audit Committee. Mr. Cohen

had a long career in the pharmaceutical industry, where he played a key

role in the development of international business for Merck & Co. While

at Merck, Mr. Cohen was a leader in the development of Merck's

international business, initially in Asia, then in Europe and,

subsequently, in all international regions as President of Merck Sharp &

Dohme, which manufactures and markets human health products outside the

"It was a great privilege to work with a man of Barry's stature," said

Michael D. West, CEO of BioTime. "His enthusiasm and energy for the

industry was infectious. We will continue to labor to advance his vision

of a brighter future for mankind through advances in medical research."

Peter Garcia, 510-521-3390, ext 367

Segall, 510-521-3390, ext 301